Literature DB >> 30336113

Alzheimer Disease: Perspectives from Epidemiology and Genetics.

Jonathan L Haines1.   

Abstract

Alzheimer disease (AD) is a huge and growing societal problem with upwards of 35% of the population over the age of 80 developing the disease. AD results in a loss of memory, the ability to make reasoned and sound decisions, and ultimately the inability to take care of oneself. AD has an impact not only on the sufferer, but their caretakers and loved ones, who must take on a costly and time-consuming burden of care. AD is found in virtually all racial and ethnic groups. Genetic influences on AD are substantial, and there has been a 30 year history of both success and failure. Mutations for rare early onset forms of the disease have been identified, but this information has not yet led to an effective treatment. Multiple common genetic variations have also been identified, and have led to new insights into the potential role of microglia cells in addition to neuronal cells in the brain. Despite intensive efforts, a significant portion of the genetic etiology of AD remains unknown and must be identified.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 30336113     DOI: 10.1177/1073110518804230

Source DB:  PubMed          Journal:  J Law Med Ethics        ISSN: 1073-1105            Impact factor:   1.718


  9 in total

1.  Alpha-lipoic acid ameliorates tauopathy-induced oxidative stress, apoptosis, and behavioral deficits through the balance of DIAP1/DrICE ratio and redox homeostasis: Age is a determinant factor.

Authors:  Elahe Zarini-Gakiye; Nima Sanadgol; Kazem Parivar; Gholamhassan Vaezi
Journal:  Metab Brain Dis       Date:  2021-02-06       Impact factor: 3.584

2.  Does SCFD1 rs10139154 Polymorphism Decrease Alzheimer's Disease Risk?

Authors:  Polyxeni Stamati; Vasileios Siokas; Athina-Maria Aloizou; Emmanouil Karampinis; Stylianos Arseniou; Valerii N Rakitskii; Aristidis Tsatsakis; Demetrios A Spandidos; Illana Gozes; Panayiotis D Mitsias; Dimitrios P Bogdanos; Georgios M Hadjigeorgiou; Efthimios Dardiotis
Journal:  J Mol Neurosci       Date:  2019-07-02       Impact factor: 3.444

3.  Effects of a Nutritional Formulation Containing Caprylic and Capric Acid, Phosphatidylserine, and Docosahexaenoic Acid in Streptozotocin-Lesioned Rats.

Authors:  Eric L R Moura; Hellin Dos Santos; Ana Paula M Celes; Taysa B Bassani; Leonardo C Souza; Maria A B F Vital
Journal:  J Alzheimers Dis Rep       Date:  2020-09-03

4.  Systemic Immune Dyshomeostasis Model and Pathways in Alzheimer's Disease.

Authors:  Puneet Talwar; Suman Kushwaha; Renu Gupta; Rachna Agarwal
Journal:  Front Aging Neurosci       Date:  2019-10-23       Impact factor: 5.750

5.  Uncovering the active compounds and effective mechanisms of the dried mature sarcocarp of Cornus officinalis Sieb. Et Zucc. For the treatment of Alzheimer's disease through a network pharmacology approach.

Authors:  Yan-Jie Qu; Rong-Rong Zhen; Li-Min Zhang; Chao Gu; Lei Chen; Xiao Peng; Bing Hu; Hong-Mei An
Journal:  BMC Complement Med Ther       Date:  2020-05-25

6.  Quantitative Trait Module-Based Genetic Analysis of Alzheimer's Disease.

Authors:  Shaoxun Yuan; Haitao Li; Jianming Xie; Xiao Sun
Journal:  Int J Mol Sci       Date:  2019-11-25       Impact factor: 5.923

7.  Telomere length and 8-hydroxy-2-deoxyguanosine as markers for early prediction of Alzheimer disease.

Authors:  Dalia H Abou-Elela; Rawhia H El-Edel; Amr S Shalaby; Mariam A Fouaad; Ahmed A Sonbol
Journal:  Indian J Psychiatry       Date:  2020-12-12       Impact factor: 1.759

Review 8.  Oxidative Stress: Glutathione and Its Potential to Protect Methionine-35 of Aβ Peptide from Oxidation.

Authors:  Pravat K Mandal; Rimil Guha Roy; Avantika Samkaria
Journal:  ACS Omega       Date:  2022-07-26

9.  Nanoporous Membranes for the Filtration of Proteins from Biological Fluids: Biocompatibility Tests on Cell Cultures and Suggested Applications for the Treatment of Alzheimer's Disease.

Authors:  Thomas Gabriel Schreiner; Bogdan Ionel Tamba; Cosmin Teodor Mihai; Adam Lőrinczi; Mihaela Baibarac; Romeo Cristian Ciobanu; Bogdan Ovidiu Popescu
Journal:  J Clin Med       Date:  2022-10-01       Impact factor: 4.964

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.